Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications

PF Hollenberg, UM Kent… - Chemical research in …, 2008 - ACS Publications
The P450 type cytochromes are responsible for the metabolism of a wide variety of
xenobiotics and endogenous compounds. Although P450-catalyzed reactions are generally …

Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?

AS Kalgutkar, G Fate, MT Didiuk… - Expert Review of Clinical …, 2008 - Taylor & Francis
It is generally accepted that bioactivation of relatively inert functional groups (toxicophores)
to reactive metabolites is an obligatory step in the pathogenesis of certain idiosyncratic …

Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug

JN Bauman, KS Frederick, A Sawant, RL Walsky… - Drug metabolism and …, 2008 - ASPET
In vitro metabolism/bioactivation of structurally related central nervous system agents
nefazodone (hepatotoxin) and aripiprazole (nonhepatotoxin) were undertaken in human …

A generic method to detect electrophilic intermediates using isotopic pattern triggered data‐dependent high‐resolution accurate mass spectrometry

HK Lim, J Chen, K Cook… - … Journal Devoted to …, 2008 - Wiley Online Library
A need still exists for a liquid chromatography/tandem mass spectrometry (LC/MS/MS)
method that can detect broad classes of glutathione (GSH) conjugates and provide …

In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery

C Prakash, R Sharma, M Gleave… - Current drug …, 2008 - ingentaconnect.com
Drug induced toxicity remains one of the major reasons for failures of new pharmaceuticals,
and for the withdrawal of approved drugs from the market. Efforts are being made to reduce …

Peptide-based in vitro assay for the detection of reactive metabolites

MD Mitchell, MM Elrick, JL Walgren… - Chemical research in …, 2008 - ACS Publications
We describe a novel peptide-based in vitro method for the detection of reactive metabolites
that is amenable for use with microsomal or purified enzyme systems. Covalently bound …

Applications of recombinant and purified human drug-metabolizing enzymes: an industrial perspective

M Yao, M Zhu, SY Chang… - Handbook of Drug …, 2008 - api.taylorfrancis.com
It has become widely accepted that in vitro metabolism studies can play a useful roleduring
the nonclinical testing of novel chemical entities (NCEs)(1-7). Therefore, mostresearchers …

Minimizing metabolic activation in drug discovery

S Kumar, TA Baillie - Handbook of Drug Metabolism, 2008 - api.taylorfrancis.com
Today's pharmaceutical industry is under a tremendous amount of pressure to cutoperating
costs, reduce cycle times for drug discovery and development, and deliver safeand effective …

5 High-Throughput Strategies

PJ Rudewicz, Q Yue, Y Shin - High-Throughput Analysis in the …, 2008 - books.google.com
The drug discovery and development processes are time consuming and costly endeavors.
It has been reported that on average it takes 10 to 15 years and costs more than $800 …

化学反応性に起因する薬物毒性メカニズムの多様性

村井孝弘 - Journal of the Mass Spectrometry Society of Japan, 2008 - jstage.jst.go.jp
抄録 A large number of electrophilic reactive metabolites, such as quinone derivatives,
Michael acceptors, nitrogen-containing electrophiles, and epoxides, are produced from drug …